Star Health and Allied Insurance Company Limited has informed the Exchange about Schedule of group Analyst/Investor meet dated November 18, 2025
Date: November 13, 2025 Place: Chennai
Ref: SHAI/B & S/SE/126/2025-26
To, The Manager Listing Department BSE Limited Phiroze Jeejeebhoy Tower Dalal Street Mumbai – 400001 Maharashtra, India. Maharashtra, India. Scrip Code: 543412
To, The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot C/1, G Block, Bandra-Kurla Complex Mumbai – 400051.
Symbol: STARHEALTH
Dear Sir/ Madam,
Sub: Analyst(s)/Institutional Investor(s) Meeting.
In compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed as Annexure - 1 the details of the group meet with Analyst(s)/ Institutional Investor(s) to be held on Tuesday, November 18, 2025, at Mumbai as part of CLSA Conference.
The link for accessing the presentation of the meeting is given below:
https://d28c6jni2fmamz.cloudfront.net/EC_Presentation_H1_Q2_FY_26_ab538a6390.pdf
The above disclosure will also be made available on the Company’s website at www.starhealth.in
Kindly take the same on record.
For Star Health and Allied Insurance Company Limited
Jayashree Sethuraman Company Secretary & Compliance Officer
Annexure – 1 Details of group meet with Investors /Analysts - November 18, 2025 Time (IST): 02.00 P.M- 02.50 P.M
Fund/Firm
Amiral Gestion
Ask Absolute Return Fund
Bay Capital Partners Ltd
First Sentier Investors (UK)
HSBC Mutual Fund
Sparx AM
Valuequest Investment
Time (IST): 03.00 P.M- 03.50 P.M
Fund/Firm
Axis Group
Bandhan Mutual Fund
Four Lion Capital Manning & Napier Max Life Insurance Co Ltd
Quantum Group
Time (IST): 05.00 P.M- 05.50 P.M
Fund/Firm
Enam AM
Quantum Group
Tata AIG General Insurance
Tribeca Inv Partners
Sl. No 1.
2.
3.
4.
5.
6.
7.
Sl. No 1.
2.
3.
4.
5.
6.
Sl. No 1.
2.
3.
4.
(Kindly note that the aforesaid meeting is subject to changes that may happen due to exigencies on the part of Analysts/Investors of the Company)